These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966 [TBL] [Abstract][Full Text] [Related]
3. Rhizomelic chondrodysplasia punctata: biochemical studies of peroxisomes isolated from cultured skin fibroblasts. Singh I; Lazo O; Contreras M; Stanley W; Hashimoto T Arch Biochem Biophys; 1991 Apr; 286(1):277-83. PubMed ID: 1680308 [TBL] [Abstract][Full Text] [Related]
4. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata. Pahan K; Khan M; Singh I J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164 [TBL] [Abstract][Full Text] [Related]
6. Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata. Balfe A; Hoefler G; Chen WW; Watkins PA Pediatr Res; 1990 Mar; 27(3):304-10. PubMed ID: 2181395 [TBL] [Abstract][Full Text] [Related]
7. Rhizomelic chondrodysplasia punctata. Deficiency of 3-oxoacyl-coenzyme A thiolase in peroxisomes and impaired processing of the enzyme. Heikoop JC; van Roermund CW; Just WW; Ofman R; Schutgens RB; Heymans HS; Wanders RJ; Tager JM J Clin Invest; 1990 Jul; 86(1):126-30. PubMed ID: 2365812 [TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata--a complementation study. Heikoop JC; Wanders RJ; Strijland A; Purvis R; Schutgens RB; Tager JM Hum Genet; 1992 Jun; 89(4):439-44. PubMed ID: 1618493 [TBL] [Abstract][Full Text] [Related]
9. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids. Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868 [TBL] [Abstract][Full Text] [Related]
10. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797 [TBL] [Abstract][Full Text] [Related]
11. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis. Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705 [TBL] [Abstract][Full Text] [Related]
13. Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata. Rizzo WB; Craft DA; Judd LL; Moser HW; Moser AB Biochem Med Metab Biol; 1993 Aug; 50(1):93-102. PubMed ID: 8373640 [TBL] [Abstract][Full Text] [Related]
14. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675 [TBL] [Abstract][Full Text] [Related]
15. Peroxisomes of normal morphology but deficient in 3-oxoacyl-CoA thiolase in rhizomelic chondrodysplasia punctata fibroblasts. Heikoop JC; Van den Berg M; Strijland A; Weijers PJ; Schutgens RB; Just WW; Wanders RJ; Tager JM Biochim Biophys Acta; 1991 Jul; 1097(1):62-70. PubMed ID: 1677591 [TBL] [Abstract][Full Text] [Related]
16. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies. Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444 [TBL] [Abstract][Full Text] [Related]
17. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949 [TBL] [Abstract][Full Text] [Related]
18. Formation of a novel arachidonic acid metabolite in peroxisomes. Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307 [TBL] [Abstract][Full Text] [Related]
19. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts. Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146 [TBL] [Abstract][Full Text] [Related]
20. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]